Drug intelligence / Profile preview

ringer's acetate (Chulalongkorn University)

Development stage
Unknown
Lead developer
Chulalongkorn University
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ringer's Acetate is a balanced crystalloid solution used for intravenous fluid resuscitation and electrolyte replacement. It is designed to mimic the electrolyte composition of human plasma more closely than isotonic saline (0.9% NaCl), thereby reducing the risk of hyperchloremic metabolic acidosis. Unlike Ringer's Lactate, which uses lactate as a buffering agent, Ringer's Acetate utilizes acetate. Acetate is rapidly metabolized to bicarbonate in various tissues, including muscles, making it potentially more suitable for patients with impaired liver function who may not metabolize lactate efficiently. It is primarily indicated for the treatment of extracellular dehydration, hypovolemia, and as a maintenance fluid in surgical and critically ill patients, such as those with sepsis or septic shock, to maintain acid-base balance and renal function.

Brand names
Sterofundin ISORinger-AcetatRinger-Acetate BaxterRinger-Acetate Fresenius
Other names
Acetated Ringer's solutionRinger-AcetateBalanced crystalloid solution
02

Targets

MG (Mycoplasma gallisepticum)

Beyond the preview

Go deeper on ringer's acetate (Chulalongkorn University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ringer's acetate (Chulalongkorn University).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call